Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
OpenAI, Microsoft and GenAI
Microsoft's VP of GenAI research to join OpenAI
Microsoft on Monday said that its vice president of GenAI research, Sebastien Bubeck, is leaving the company to join ChatGPT-maker OpenAI.
Microsoft’s AI research VP joins OpenAI amid fight for top AI talent
High-profile exits from OpenAI, and now Microsoft, signal fierce competition for AI talent as big tech companies race toward developing artificial general intelligence (AGI), with top executives shifting between industry leaders.
Microsoft's VP for GenAI development Sebastien Bubeck leaves company to work with Sam Altman at OpenAI
Bubeck’s exit follows his key involvement in Microsoft’s development of Phi LLMs, a more compact version of traditional AI models. Despite his departure, Microsoft has confirmed that research in this area will continue,
Microsoft’s VP of GenAI Research Will Join OpenAI in Major AI Shift
Microsoft’s VP of GenAI research will join OpenAI, marking a significant shift in the AI talent landscape. Sebastien Bubeck, Microsoft’s Vice President of Generative AI (GenAI) research, has left the company to join OpenAI,
Microsoft’s GenAI Research VP Leaves Firm For OpenAI
Sebastien Bubeck, Microsoft’s vice president of GenAI research, said on Monday that he is leaving the firm to go for ChatGPT creator OpenAI. TakeAway Points: Microsoft on Monday said that its vice president of GenAI research,
Microsoft's Vice President of GenAI research to join OpenAI
The development follows a series of departures from OpenAI, including that of longtime chief technology officer Mira Murati in September.
Microsoft's VP of GenAI research Sebastien Bubeck to join OpenAI
Microsoft on Monday said that its vice president of GenAI research, Sebastien Bubeck, is leaving the company to join ChatGPT-maker OpenAI. It was unclear what role Bubeck would assume at the Microsoft-backed AI startup.
Microsoft's GenAI research VP heads to OpenAI
Sebastien Bubeck, the Vice President of Generative AI research at Microsoft, has left the tech giant to join OpenAI, the company behind ChatGPT. The exact role Bubeck will take on at the Sam Altman-led firm is not known yet. A Microsoft spokesperson confirmed the move by Bubeck, and expressed hope for future collaborations with him.
Microsoft VP of GenAI research Sebastien Bubeck to join ChatGPT parent OpenAI
Sebastien Bubeck, Microsoft's vice president of GenAI research, is leaving to join OpenAI. His colleagues will continue their work at Microsoft on Phi LLMs. Bubeck's move comes amidst increasing autonomy for OpenAI from Microsoft's cloud services and significant recent fundraising.
Microsoft’s (NASDAQ:MSFT) VP of AI Research Departs for OpenAI
Leading technology company Microsoft ($MSFT) has announced that its vice president of generative artificial intelligence (AI) research is leaving
1h
Here’s how Cleary Gottlieb law firm uses genAI for pre-trial discovery and more
Like many law firms, Cleary Gotlieb relies on genAI to tackle a myriad of tasks, from combing through millions of electronic ...
2d
on MSN
Sam Altman-Led OpenAI Welcomes Microsoft's GenAI Research VP Following Wave Of Executive Departures
Sebastien Bubeck, the vice president of GenAI research at Microsoft Corporation (NASDAQ:MSFT) is set to join ChatGPT-parent, ...
2d
on MSN
OpenAI Poaches Leading Microsoft AI Expert in Coup for ChatGPT
Sebastien Bubeck jumps ship to "further his work toward developing AGI" at OpenAI, leaving his Microsoft role of over 10 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
One Direction singer dies
Fox News interview
Exotic cat caught in suburb
NH justice indicted
Italy expands surrogacy ban
Felon voting rights upheld
Disney to debut new pass
Gets minimum 28 years
To return to Atlanta in 2028
New cervical cancer regimen
Cereal dyes protested
Ordered to pay $15 million
Had benign cyst removed
AL voter roll purge blocked
'Click to cancel' finalized
21K+ SUVs recalled
Abortion group sues Florida
FDA halts Novavax trial
To headline Atlanta rally
GA election rules blocked
Synthetic nicotine pouches
To invest in nuclear reactors
Allows EPA emissions rule
SpaceX sues CA regulators
MI shooter drill settlement
To cut up to 2,500 jobs
Sentenced for cartel bribery
To settle US bribery probe
Feedback